Phase NA × Lymphoma, T-Cell, Cutaneous × Filgrastim × Clear all
NCT00547196 2024-06-14

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

City of Hope Medical Center

Phase NA Completed
10 enrolled 11 charts
NCT01408043 2019-06-14

Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma

Case Comprehensive Cancer Center

Phase NA Terminated
25 enrolled 15 charts
NCT00290628 2017-11-29

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
43 enrolled
NCT01076270 2017-06-28

Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Fred Hutchinson Cancer Center

Phase NA Terminated
1 enrolled 7 charts
NCT00253552 2012-05-28

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

OHSU Knight Cancer Institute

Phase NA Terminated
4 enrolled